A major hurdle to successful cancer treatment is tumour resistance to chemotherapy. White blood cells called macrophages often infiltrate tumours in large numbers, and now appear to promote tumour chemoresistance.
References
de Visser, K. E., Eichten, A., Coussens, L. M. Nature Rev. Cancer 6, 24–37 (2006).
Mellor, A. L. & Munn, D. H. Nature Rev. Immunol. 8, 74–80 (2008).
Lewis, C. E. & Pollard, J. W. Cancer Res. 66, 605–612 (2006).
DeNardo, D. G. et al. Cancer Discov. 10.1158/2159-8274.CD-10-0028 (2011).
DeNardo, D. G., Andreu, P. & Coussens, L. M. Cancer Metastasis Rev. 29, 309–316 (2010).
Andreu, P. et al. Cancer Cell 17, 121–134 (2010).
Bingle, L., Brown, N. J. & Lewis, C. E. J. Pathol. 196, 254–265 (2002).
Galon, J. et al. Science 313, 1960–1964 (2006).
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D. & Aharinejad, S. Cancer Res. 66, 4349–4356 (2006).
Pucci, F. et al. Blood 114, 901–914 (2009).
Stockmann, C. et al. Nature 456, 814–818 (2008).
Rolny, C. et al. Cancer Cell 19, 31–44 (2011).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
De Palma, M., Lewis, C. Macrophages limit chemotherapy. Nature 472, 303–304 (2011). https://doi.org/10.1038/472303a
Published:
Issue Date:
DOI: https://doi.org/10.1038/472303a
- Springer Nature Limited
This article is cited by
-
CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
Biology Direct (2022)
-
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer
Cancer Immunology, Immunotherapy (2021)
-
VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues
Scientific Reports (2019)
-
Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors
Scientific Reports (2019)
-
Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
Cell Death & Disease (2018)